Detalles de la búsqueda
1.
PD-1 Blockade with Cemiplimab in Advanced Cutaneous Squamous-Cell Carcinoma.
N Engl J Med
; 379(4): 341-351, 2018 07 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-29863979
2.
Cemiplimab in locally advanced cutaneous squamous cell carcinoma: results from an open-label, phase 2, single-arm trial.
Lancet Oncol
; 21(2): 294-305, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31952975
3.
Multisite prospective study of perioperative pain management practices for anterior cruciate ligament reconstruction in adolescents: Society for Pediatric Anesthesia Improvement Network (SPAIN) Project Report.
Reg Anesth Pain Med
; 2024 Apr 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-38637132
4.
Erector spinae plane blocks for opioid-sparing multimodal pain management after pediatric cardiac surgery.
J Thorac Cardiovasc Surg
; 2024 Mar 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-38493959
5.
High response rate with extended dosing of cemiplimab in advanced cutaneous squamous cell carcinoma.
J Immunother Cancer
; 12(3)2024 03 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-38471711
6.
Integrated analysis of a phase 2 study of cemiplimab in advanced cutaneous squamous cell carcinoma: extended follow-up of outcomes and quality of life analysis.
J Immunother Cancer
; 9(8)2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-34413166
7.
Phase 2 study of cemiplimab in patients with metastatic cutaneous squamous cell carcinoma: primary analysis of fixed-dosing, long-term outcome of weight-based dosing.
J Immunother Cancer
; 8(1)2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32554615
8.
An international expanded-access programme of everolimus: addressing safety and efficacy in patients with metastatic renal cell carcinoma who progress after initial vascular endothelial growth factor receptor-tyrosine kinase inhibitor therapy.
Eur J Cancer
; 48(3): 324-32, 2012 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-21803569
Resultados
1 -
8
de 8
1
Próxima >
>>